Here are Steven’s Poster Picks for Tuesday, May 7, 2019:

Multiple sclerosis

1. Progressive MS: Siponimod (P3.2-051), ocrelizumab (P3.2-031, P3.2-042), biotin (P3.2-038, P3.2-043, P3.2-063), ibudilast (P3.2-049)
2. Neurofilament-light and DMTs: Fingolimod (P3.2-032), alemtuzumab (P3.2-045), ibudilast (P3.2-033), SCT (P3.2-039)
3. Long-term data: DMF (P3.2-084), alemtuzumab (P3.2-037, P3.2-067), ocrelizumab (P3.2-054), IFNb-1b (P3.2-080), PEG-IFN-1a (P3.2-082)
4. Sequencing studies (P3.2-050, P3.2-056, P3.2-070, P3.2-075, P3.2-103)
5. Brain atrophy: DMF (P3.2-064)
6. Real-world studies: DMF (P3.2-081)
7. Clinical tips: Steroid resistance (P3.2-089)

Read More

Here are Steven’s Poster Picks for Monday, May 6, 2019:

Migraine

1. Long-term data for frenezumab (P2.10-002, P2.10-008, P2.10-015) and galcanezumab (P2.10-010)
2. Safety of ubrogepant (P2.10-003, P2.10-009)

Read More